美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

REIN THERAPEUTICS INC

1.35

-0.0400-2.88%

盘后：1.400.0500+3.70%18:47 EDT

成交量：24.23万

成交额：31.83万

市值：3,146.19万

市盈率：-0.51

高：1.38

开：1.34

低：1.23

收：1.39

52周最高：4.40

52周最低：1.04

股本：2,330.51万

流通股本：1,978.54万

量比：1.30

换手率：1.22%

股息：- -

股息率：- -

每股收益(TTM):-2.6428

每股收益(LYR):-3.5054

净资产收益率：-79.38%

总资产收益率：-18.24%

市净率：10.46

市盈率(LYR):-0.39

数据加载中...

总览公司新闻公告

Rein Therapeutics Inc 预计每股亏损 25 美分 - 财报前瞻

Rein Therapeutics Inc 预计每股亏损 22 美分 - 财报前瞻

总规模470亿港币，晶泰科技创AI药物发现合作订单新纪录

美国 FDA搁置肺病试验后，Rein Therapeutics 暂停给药

Rein Therapeutics Inc 预计每股亏损 24 美分 - 财报前瞻

Rein Therapeutics, Inc.2024财年实现净利润-62.88百万美元，同比减少299.75%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/RNTX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","market":"US","secType":"STK","nameCN":"REIN THERAPEUTICS INC","latestPrice":1.35,"timestamp":1756843200000,"preClose":1.39,"halted":0,"volume":242342,"hourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.35,"latestTime":"18:47 EDT","volume":590,"amount":825.77,"timestamp":1756853278625},"delay":0,"floatShares":19785370,"shares":23305108,"eps":-2.642829,"marketStatus":"已收盘","change":-0.04,"latestTime":"09-02 16:00:00 EDT","open":1.34,"high":1.375,"low":1.23,"amount":318328.45527100004,"amplitude":0.104317,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.642829,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756886400000},"marketStatusCode":5,"adr":0,"listingDate":1498708800000,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.33,"preClose":1.39,"latestTime":"09:18 EDT","volume":3481,"amount":4728.1246422,"timestamp":1756819135526},"postHourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.35,"latestTime":"18:47 EDT","volume":590,"amount":825.77,"timestamp":1756853278625},"volumeRatio":1.302705},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNTX\",,,,,undefined,":{"symbol":"RNTX","floatShares":19785370,"roa":"-18.24%","roe":"-79.38%","lyrEps":-3.505399,"volumeRatio":1.302705,"shares":23305108,"dividePrice":0,"high":1.375,"amplitude":0.104317,"preClose":1.39,"low":1.23,"week52Low":1.04,"pbRate":"10.46","week52High":4.4,"institutionHeld":0,"latestPrice":1.35,"eps":-2.642829,"divideRate":0,"volume":242342,"delay":0,"ttmEps":-2.642829,"open":1.34,"prevYearClose":2.3,"prevWeekClose":1.39,"prevMonthClose":1.39,"prevQuarterClose":1.4,"fiveDayClose":1.18,"twentyDayClose":1.12,"sixtyDayClose":1.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"RNTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-05-15","symbol":"RNTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-04-07","symbol":"RNTX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"RNTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-08-14","symbol":"RNTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.25,"name":null,"time":"盘后","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1755748800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNTX","date":"2025-08-29","current":-0.445213,"percent":0.910828,"low":-2.000549,"twenty":-1.478924,"median":-0.689114,"eighty":-0.516321,"high":-0.401342,"avg":-0.926675,"sd":0.482428,"marketCap":26334772},"quantilePoints":[{"date":"2025-01-17","current":-1.459659,"twenty":-1.48337,"median":-1.467068,"eighty":-1.447804,"marketCap":42681903},{"date":"2025-01-24","current":-1.630077,"twenty":-1.576729,"median":-1.478183,"eighty":-1.446322,"marketCap":47665070},{"date":"2025-01-31","current":-1.467069,"twenty":-1.741219,"median":-1.496707,"eighty":-1.462623,"marketCap":42898563},{"date":"2025-02-07","current":-1.704171,"twenty":-1.704171,"median":-1.526344,"eighty":-1.459659,"marketCap":49831664},{"date":"2025-02-14","current":-1.741218,"twenty":-1.704171,"median":-1.578211,"eighty":-1.462623,"marketCap":50914961},{"date":"2025-02-21","current":-1.98573,"twenty":-1.794566,"median":-1.630077,"eighty":-1.468551,"marketCap":58064721},{"date":"2025-02-28","current":-1.533754,"twenty":-1.79753,"median":-1.630077,"eighty":-1.47596,"marketCap":44848497},{"date":"2025-03-07","current":-1.467069,"twenty":-1.753073,"median":-1.607848,"eighty":-1.468551,"marketCap":42898563},{"date":"2025-03-14","current":-1.496707,"twenty":-1.741218,"median":-1.552277,"eighty":-1.467069,"marketCap":43765200},{"date":"2025-03-21","current":-1.430022,"twenty":-1.733809,"median":-1.518935,"eighty":-1.461141,"marketCap":41815266},{"date":"2025-03-28","current":-1.311471,"twenty":-1.704171,"median":-1.507821,"eighty":-1.431504,"marketCap":38348715},{"date":"2025-04-04","current":-1.259605,"twenty":-1.704171,"median":-1.496707,"eighty":-1.416685,"marketCap":36832099},{"date":"2025-04-11","current":-0.545587,"twenty":-1.696762,"median":-1.481888,"eighty":-1.32629,"marketCap":34308123},{"date":"2025-04-17","current":-0.577063,"twenty":-1.667124,"median":-1.474478,"eighty":-1.296652,"marketCap":36287438},{"date":"2025-04-25","current":-0.640015,"twenty":-1.630077,"median":-1.467069,"eighty":-1.259605,"marketCap":40246068},{"date":"2025-05-02","current":-0.573565,"twenty":-1.630077,"median":-1.459659,"eighty":-0.64701,"marketCap":36067514},{"date":"2025-05-09","current":-0.601544,"twenty":-1.630077,"median":-1.437431,"eighty":-0.622528,"marketCap":37826905},{"date":"2025-05-16","current":-0.825375,"twenty":-1.622667,"median":-1.430022,"eighty":-0.622528,"marketCap":51902033},{"date":"2025-05-23","current":-0.696336,"twenty":-1.607848,"median":-1.415203,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-05-30","current":-0.696336,"twenty":-1.584138,"median":-1.407793,"eighty":-0.629523,"marketCap":42665230},{"date":"2025-06-06","current":-0.705061,"twenty":-1.560428,"median":-1.311471,"eighty":-0.635119,"marketCap":43199785},{"date":"2025-06-13","current":-0.712292,"twenty":-1.550055,"median":-1.296652,"eighty":-0.639316,"marketCap":43642859},{"date":"2025-06-20","current":-0.592974,"twenty":-1.539682,"median":-1.259605,"eighty":-0.638616,"marketCap":36332127},{"date":"2025-06-27","current":-0.524276,"twenty":-1.524863,"median":-1.24849,"eighty":-0.622528,"marketCap":32122917},{"date":"2025-07-03","current":-0.54597,"twenty":-1.518935,"median":-0.809312,"eighty":-0.609134,"marketCap":33452141},{"date":"2025-07-11","current":-0.535123,"twenty":-1.515971,"median":-0.771713,"eighty":-0.598047,"marketCap":32787529},{"date":"2025-07-18","current":-0.506198,"twenty":-1.508562,"median":-0.726755,"eighty":-0.578462,"marketCap":31015230},{"date":"2025-07-25","current":-0.513429,"twenty":-1.504116,"median":-0.717873,"eighty":-0.562281,"marketCap":31458305},{"date":"2025-08-01","current":-0.421229,"twenty":-1.501152,"median":-0.708677,"eighty":-0.556817,"marketCap":25809102},{"date":"2025-08-08","current":-0.417509,"twenty":-1.496707,"median":-0.703515,"eighty":-0.543648,"marketCap":25581194},{"date":"2025-08-15","current":-0.434435,"twenty":-1.490779,"median":-0.698131,"eighty":-0.532953,"marketCap":26618269},{"date":"2025-08-22","current":-0.445213,"twenty":-1.481888,"median":-0.696336,"eighty":-0.524276,"marketCap":26334772},{"date":"2025-08-29","current":-0.445213,"twenty":-1.478924,"median":-0.689114,"eighty":-0.516321,"marketCap":26334772}],"updateTime":1756835495533},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559946180","title":"Rein Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2559946180","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559946180?lang=zh_cn&edition=fundamental","pubTime":"2025-08-16 04:37","pubTimestamp":1755290226,"startTime":"0","endTime":"0","summary":"Rein Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻) Rein Therapeutics Inc RNTX.OQ RNTX.O将于8月18日公布截至2025年9月30日的财报(，预计季度收入不会有变化。LSEG分析师对Rein Therapeutics Inc的平均预期是每股亏损25美分。华尔街对 Rein Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，比上次收盘价 1.16 美元高出约 83.5%。8月15日 - 本摘要于北京时间 8 月 15 日 20:37 由机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nL4T3U716H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX"],"gpt_icon":0},{"id":"2558570982","title":"Rein Therapeutics Inc  预计每股亏损 22 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2558570982","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558570982?lang=zh_cn&edition=fundamental","pubTime":"2025-08-09 07:05","pubTimestamp":1754694309,"startTime":"0","endTime":"0","summary":"Rein Therapeutics Inc  预计每股亏损 22 美分 - 财报前瞻) Rein Therapeutics Inc RNTX.OQ RNTX.O将于8月12日公布截至2025年6月30日的财报(，预计季度营收不会有变化。LSEG的分析师平均预计Rein Therapeutics Inc每股亏损22美分。华尔街对 Rein Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，比上次收盘价 1.11 美元高出约 84.1%。8月8日 - 本摘要于北京时间 8 月 8 日 23:05 由机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL4S3U02MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX"],"gpt_icon":0},{"id":"2557317799","title":"总规模470亿港币，晶泰科技创AI药物发现合作订单新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2557317799","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557317799?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 00:53","pubTimestamp":1754412780,"startTime":"0","endTime":"0","summary":"根据协议条款，晶泰科技与 DoveTree 就多款处于临床前阶段的大分子及小分子创新药资产达成合作，并将针对一系列 DoveTree 指定的靶点进行新药研发，DoveTree 独家享有相关药物全球范围的独家开发和商业化权利。此次合作创下人工智能+机器人新药研发领域订单规模的新纪录。这使得晶泰科技成为极其难得的战略合作伙伴，并将有机会深刻变革药物发现的合作模式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744811_ZH44811_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1141","RNTX","BK1617","ENTA","02228","BK4231","BK4139","BK4080","ADC"],"gpt_icon":0},{"id":"2543547552","title":"美国 FDA搁置肺病试验后，Rein Therapeutics 暂停给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2543547552","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543547552?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 04:34","pubTimestamp":1749760486,"startTime":"0","endTime":"0","summary":"美国 FDA搁置肺病试验后，Rein Therapeutics 暂停给药路透6月12日 - Rein Therapeutics RNTX.O周四表示，在美国食品和药物管理局对其肺病药物的一项中期临床试验进行搁置后，该公司已暂停了在美国的入组和患者给药。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nL4T3SF1EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX","BK4139"],"gpt_icon":0},{"id":"2534646676","title":"Rein Therapeutics Inc  预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2534646676","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534646676?lang=zh_cn&edition=fundamental","pubTime":"2025-05-10 05:46","pubTimestamp":1746827167,"startTime":"0","endTime":"0","summary":"Rein Therapeutics Inc  预计每股亏损 24 美分 - 财报前瞻Rein Therapeutics Inc RNTX.OQ RNTX.O将于5月13日公布截至3月31日的业绩。LSEG分析师对Rein Therapeutics Inc的平均预期是每股亏损24美分。华尔街对 Rein Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 1.72 美元。5月9日 - 本摘要于北京时间 5 月 9 日 21:46 机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL4T3RH26Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNTX"],"gpt_icon":0},{"id":"2525904988","title":"Rein Therapeutics, Inc.2024财年实现净利润-62.88百万美元，同比减少299.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525904988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525904988?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 20:00","pubTimestamp":1744113618,"startTime":"0","endTime":"0","summary":"4月8日，Rein Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-62.88百万美元，同比减少299.75%；其中营业收入为0.00美元，每股基本收益为-3.51美元。从资产负债表来看，Rein Therapeutics, Inc.总负债14.85百万美元，其中短期债务0.00美元，资产负债比为4.67，流动比率为2.38。机构评级：截至2025年4月8日，当前有2家机构对Rein Therapeutics, Inc.目标价做出预测，其中目标均价为10.50美元，其中最低目标价为8.00美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408200020a452589a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408200020a452589a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNTX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}